6 December 2019: ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, is pleased to announce its interim results for the six months ended 30 September 2019.
To log on to view a recording of the analyst presentation webcast please click here…
To view the Interim Results Presentation slide deck please click here…